United States Biotechnology & Medical Research

Trevi Therapeutics, Inc. (TRVI)

Track

Track

Trevi Therapeutics experienced significant insider trading activity recently, characterized exclusively by sales. Director Michael Heffernan executed multiple planned divestments totaling over 1.2 million dollars in mid-September. These transactions occurred following the August results financiers, amidst a ninety-day stock price decline of twenty-one percent despite shares trading near their annual peak.
Ticker: TRVI Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Trevi Therapeutics, Inc.. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Heffernan Michael Thomas Non-Executive Director
Transaction date
Planned sale
Price
180.67
Quantity 97,004 +46.2%
Value US$999,242
Heffernan Michael Thomas Non-Executive Director
Transaction date
Planned sale
Price
287.84
Quantity 87,082 -24.0%
Value US$1,405,800
Heffernan Michael Thomas Non-Executive Director
Transaction date
Planned sale
Price
284.91
Quantity 5,823 +14.3%
Value US$2,938,972
Heffernan Michael Thomas Non-Executive Director
Transaction date
Planned sale
Price
15.09
Quantity 1,000 -74.0%
Value US$100,000
MICHAEL HEFFERNAN Director Non-Executive Director
Transaction date
Proposed sale
Price
15.89
Quantity 1,000
Value US$100,000
Delfini Lisa Officer Officer
Transaction date
Proposed sale
Price
9.50
Quantity 108,650
Value US$1,032,175
Delfini Lisa Officer Officer
Transaction date
Proposed sale
Price
9.67
Quantity 40,000
Value US$386,716
Delfini Lisa Officer Officer
Transaction date
Proposed sale
Price
8.09
Quantity 312,855
Value US$2,532,530
1.7
SCIASCIA THOMAS Chief Scientific Officer Officer
Transaction date
Sale
Price
6.60
Quantity 2,631 -1.2%
Value US$17,365
2.9
GOOD JENNIFER L President & CEO Executive Director
Transaction date
Sale
Price
6.58
Quantity 5,263 -2.4%
Value US$34,625
2.9
GOOD JENNIFER L Officer Officer
Transaction date
Proposed sale
Price
6.58
Quantity 5,263
Value US$34,625
Simon Farrell Chief Commercial Officer Officer
Transaction date
Planned sale
Price
7.15
Quantity 4,350 -5.4%
Value US$31,102
Simon Farrell Chief Commercial Officer Officer
Transaction date
Planned sale
Price
6.73
Quantity 76,963 -48.6%
Value US$517,776
Simon Farrell Officer Officer
Transaction date
Proposed sale
Price
6.75
Quantity 81,313
Value US$548,880
2.9
GOOD JENNIFER L President & CEO Executive Director
Transaction date
Sale
Price
3.04
Quantity 1,840 -0.9%
Value US$5,587
2.9
GOOD JENNIFER L President & CEO Executive Director
Transaction date
Sale
Price
3.03
Quantity 4,219 -1.9%
Value US$12,784
2.9
GOOD JENNIFER L President & CEO Executive Director
Transaction date
Sale
Price
3.11
Quantity 40,277 -15.9%
Value US$125,310
2.9
GOOD JENNIFER L President & CEO Executive Director
Transaction date
Sale
Price
3.02
Quantity 10,981 -4.9%
Value US$33,205
2.9
GOOD JENNIFER L President & CEO Executive Director
Transaction date
Sale
Price
3.02
Quantity 3,863 -1.8%
Value US$11,677
2.9
GOOD JENNIFER L Officer Officer
Transaction date
Proposed sale
Price
3.16
Quantity 61,180
Value US$193,328
1.2
Meeker David P Non-Executive Director
Transaction date
Sale
Price
2.93
Quantity 4,555 -1.3%
Value US$13,353
1.2
Meeker David P Officer Officer
Transaction date
Proposed sale
Price
2.98
Quantity 4,555
Value US$13,573
1.7
SCIASCIA THOMAS Chief Scientific Officer Officer
Transaction date
Sale
Price
2.96
Quantity 16,496 -7.0%
Value US$48,883
1.7
SCIASCIA THOMAS Chief Scientific Officer Officer
Transaction date
Sale
Price
2.76
Quantity 18,660 -7.8%
Value US$51,440
1.7
SCIASCIA THOMAS Chief Scientific Officer Officer
Transaction date
Sale
Price
2.79
Quantity 12,745 -5.5%
Value US$35,513
1.7
SCIASCIA THOMAS Officer Officer
Transaction date
Proposed sale
Price
2.61
Quantity 48,001
Value US$125,282
1.7
SCIASCIA THOMAS Officer Officer
Transaction date
Proposed sale
Price
2.61
Quantity 48,001
Value US$125,282
1.7
SCIASCIA THOMAS Chief Scientific Officer Officer
Transaction date
Sale
Price
2.75
Quantity 100 -0.0%
Value US$275
1.7
SCIASCIA THOMAS Chief Scientific Officer Officer
Transaction date
Planned sale
Price
2.55
Quantity 53,368 -19.9%
Value US$136,110
1.7
SCIASCIA THOMAS Officer Officer
Transaction date
Proposed sale
Price
2.56
Quantity 53,368
Value US$136,622
Delfini Lisa Chief Financial Officer Officer
Transaction date
Planned sale
Price
2.64
Quantity 4,350 -7.5%
Value US$11,485
2.9
GOOD JENNIFER L President & CEO Executive Director
Transaction date
Sale
Price
2.86
Quantity 25,037 -10.5%
Value US$71,576
2.9
GOOD JENNIFER L President & CEO Executive Director
Transaction date
Planned sale
Price
2.90
Quantity 4,578 -2.1%
Value US$13,276
Delfini Lisa Chief Financial Officer Officer
Transaction date
Planned sale
Price
2.02
Quantity 785 -2.1%
Value US$1,586
Delfini Lisa Chief Financial Officer Officer
Transaction date
Planned sale
Price
2.20
Quantity 711 -2.0%
Value US$1,564
Delfini Lisa Officer Officer
Transaction date
Proposed sale
Price
2.16
Quantity 1,600
Value US$3,456
Delfini Lisa Chief Financial Officer Officer
Transaction date
Planned sale
Price
2.36
Quantity 682 -2.0%
Value US$1,610
Delfini Lisa Chief Financial Officer Officer
Transaction date
Planned sale
Price
2.34
Quantity 687 -2.2%
Value US$1,608
Delfini Lisa Chief Financial Officer Officer
Transaction date
Planned sale
Price
2.64
Quantity 610 -2.0%
Value US$1,610
Delfini Lisa Officer Officer
Transaction date
Proposed sale
Price
2.57
Quantity 1,615
Value US$4,150
Delfini Lisa Chief Financial Officer Officer
Transaction date
Planned sale
Price
2.89
Quantity 562 -2.0%
Value US$1,624
Delfini Lisa Chief Financial Officer Officer
Transaction date
Planned sale
Price
1.84
Quantity 840 -3.1%
Value US$1,545
Delfini Lisa Officer Officer
Transaction date
Proposed sale
Price
1.84
Quantity 1,900
Value US$3,496
Delfini Lisa Chief Financial Officer Officer
Transaction date
Planned sale
Price
1.75
Quantity 892 -3.5%
Value US$1,564
Delfini Lisa Chief Financial Officer Officer
Transaction date
Planned sale
Price
2.45
Quantity 8,474 -26.6%
Value US$20,761
3.0
TPG GP A, LLC
Transaction date
Sale
Price
3.11
Quantity 63,569 -1.6%
Value US$197,827
3.0
TPG GP A, LLC
Transaction date
Sale
Price
2.86
Quantity 436,431 -10.1%
Value US$1,246,185
3.0
TPG GP A, LLC Large shareholder
Transaction date
Sale
Price
2.77
Quantity 429,838 -9.0%
Value US$1,191,898
3.0
TPG GP A, LLC Large shareholder
Transaction date
Sale
Price
2.74
Quantity 46,128 -1.0%
Value US$126,303
3.0
TPG GP A, LLC Large shareholder
Transaction date
Sale
Price
2.70
Quantity 600 -0.0%
Value US$1,620
3.0
TPG GP A, LLC Large shareholder
Transaction date
Sale
Price
2.75
Quantity 16,163 -0.3%
Value US$44,385
3.0
TPG GP A, LLC Large shareholder
Transaction date
Sale
Price
2.77
Quantity 7,271 -0.2%
Value US$20,140
2.5
BASKETT FOREST Large shareholder
Transaction date
Purchase
Price
1.90
Quantity 2,631,578 +33.8%
Value US$4,999,998
3.9
Walker Paul Edward Large shareholder
Transaction date
Purchase
Price
1.90
Quantity 948,948 +inf%
Value US$1,803,001
3.9
Walker Paul Edward Large shareholder
Transaction date
Purchase
Price
1.90
Quantity 2,631,578 +33.8%
Value US$4,999,998
2.8
Makhzoumi Mohamad Large shareholder
Transaction date
Purchase
Price
1.90
Quantity 948,948 +inf%
Value US$1,803,001
2.8
Makhzoumi Mohamad Large shareholder
Transaction date
Purchase
Price
1.90
Quantity 2,631,578 +33.8%
Value US$4,999,998
1.5
Behbahani Ali Large shareholder
Transaction date
Purchase
Price
1.90
Quantity 948,948 +inf%
Value US$1,803,001
1.5
Behbahani Ali Large shareholder
Transaction date
Purchase
Price
1.90
Quantity 2,631,578 +33.8%
Value US$4,999,998
2.4
SANDELL SCOTT D Large shareholder
Transaction date
Purchase
Price
1.90
Quantity 948,948 +inf%
Value US$1,803,001
2.4
SANDELL SCOTT D Large shareholder
Transaction date
Purchase
Price
1.90
Quantity 2,631,578 +33.8%
Value US$4,999,998
3.6
Chang Carmen Large shareholder
Transaction date
Purchase
Price
1.90
Quantity 948,948 +inf%
Value US$1,803,001
3.6
Chang Carmen Large shareholder
Transaction date
Purchase
Price
1.90
Quantity 2,631,578 +33.8%
Value US$4,999,998
2.1
Sonsini Peter W. Large shareholder
Transaction date
Purchase
Price
1.90
Quantity 948,948 +inf%
Value US$1,803,001
2.1
Sonsini Peter W. Large shareholder
Transaction date
Purchase
Price
1.90
Quantity 2,631,578 +33.8%
Value US$4,999,998
2.7
Florence Anthony A. Jr. Large shareholder
Transaction date
Purchase
Price
1.90
Quantity 948,948 +inf%
Value US$1,803,001
2.7
Florence Anthony A. Jr. Large shareholder
Transaction date
Purchase
Price
1.90
Quantity 2,631,578 +33.8%
Value US$4,999,998
1.5
Behbahani Ali Large shareholder
Transaction date
Purchase
Price
0.00
Quantity 1,851,852
Value US$0
3.6
Chang Carmen Large shareholder
Transaction date
Purchase
Price
0.00
Quantity 1,851,852
Value US$0
2.5
BASKETT FOREST Large shareholder
Transaction date
Purchase
Price
0.00
Quantity 1,851,852
Value US$0
2.8
Makhzoumi Mohamad Large shareholder
Transaction date
Purchase
Price
0.00
Quantity 1,851,852
Value US$0
2.4
SANDELL SCOTT D Large shareholder
Transaction date
Purchase
Price
0.00
Quantity 1,851,852
Value US$0
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-17 2026-09-15 PlS Planned sale
Heffernan Michael Thomas
Non-Executive Director
97,004 +46.2%
180.67
US$999,242 		97,004 +46.2% 180.67 US$999,242
2026-09-17 2026-09-15 PlS Planned sale
Heffernan Michael Thomas
Non-Executive Director
87,082 -24.0%
287.84
US$1,405,800 		87,082 -24.0% 287.84 US$1,405,800
2026-09-17 2026-09-15 PlS Planned sale
Heffernan Michael Thomas
Non-Executive Director
5,823 +14.3%
284.91
US$2,938,972 		5,823 +14.3% 284.91 US$2,938,972
2026-09-17 2026-09-15 PlS Planned sale
Heffernan Michael Thomas
Non-Executive Director
1,000 -74.0%
15.09
US$100,000 		1,000 -74.0% 15.09 US$100,000
2026-09-15 2026-09-15 PrS Proposed sale
MICHAEL HEFFERNAN

Director

Non-Executive Director
1,000
15.89
US$100,000 		1,000 15.89 US$100,000
2025-10-07 2025-10-07 PrS Proposed sale
Delfini Lisa

Officer

Officer
108,650
9.50
US$1,032,175 		108,650 9.50 US$1,032,175
2025-10-03 2025-10-03 PrS Proposed sale
Delfini Lisa

Officer

Officer
40,000
9.67
US$386,716 		40,000 9.67 US$386,716
2025-08-27 2025-08-27 PrS Proposed sale
Delfini Lisa

Officer

Officer
312,855
8.09
US$2,532,530 		312,855 8.09 US$2,532,530
2025-03-26 2025-03-25 S Sale
1.7
SCIASCIA THOMAS

Chief Scientific Officer

Officer
2,631 -1.2%
6.60
US$17,365 		2,631 -1.2% 6.60 US$17,365
2025-03-25 2025-03-21 S Sale
2.9
GOOD JENNIFER L

President & CEO

Executive Director
5,263 -2.4%
6.58
US$34,625 		5,263 -2.4% 6.58 US$34,625
2025-03-21 2025-03-21 PrS Proposed sale
2.9
GOOD JENNIFER L

Officer

Officer
5,263
6.58
US$34,625 		5,263 6.58 US$34,625
2025-03-12 2025-03-10 PlS Planned sale
Simon Farrell

Chief Commercial Officer

Officer
4,350 -5.4%
7.15
US$31,102 		4,350 -5.4% 7.15 US$31,102
2025-03-12 2025-03-10 PlS Planned sale
Simon Farrell

Chief Commercial Officer

Officer
76,963 -48.6%
6.73
US$517,776 		76,963 -48.6% 6.73 US$517,776
2025-03-10 2025-03-10 PrS Proposed sale
Simon Farrell

Officer

Officer
81,313
6.75
US$548,880 		81,313 6.75 US$548,880
2024-09-09 2024-09-09 S Sale
2.9
GOOD JENNIFER L

President & CEO

Executive Director
1,840 -0.9%
3.04
US$5,587 		1,840 -0.9% 3.04 US$5,587
2024-09-09 2024-09-06 S Sale
2.9
GOOD JENNIFER L

President & CEO

Executive Director
4,219 -1.9%
3.03
US$12,784 		4,219 -1.9% 3.03 US$12,784
2024-09-05 2024-09-05 S Sale
2.9
GOOD JENNIFER L

President & CEO

Executive Director
40,277 -15.9%
3.11
US$125,310 		40,277 -15.9% 3.11 US$125,310
2024-09-05 2024-09-04 S Sale
2.9
GOOD JENNIFER L

President & CEO

Executive Director
10,981 -4.9%
3.02
US$33,205 		10,981 -4.9% 3.02 US$33,205
2024-09-05 2024-09-03 S Sale
2.9
GOOD JENNIFER L

President & CEO

Executive Director
3,863 -1.8%
3.02
US$11,677 		3,863 -1.8% 3.02 US$11,677
2024-09-03 2024-09-03 PrS Proposed sale
2.9
GOOD JENNIFER L

Officer

Officer
61,180
3.16
US$193,328 		61,180 3.16 US$193,328
2024-08-29 2024-08-27 S Sale
1.2
Meeker David P
Non-Executive Director
4,555 -1.3%
2.93
US$13,353 		4,555 -1.3% 2.93 US$13,353
2024-08-27 2024-08-27 PrS Proposed sale
1.2
Meeker David P

Officer

Officer
4,555
2.98
US$13,573 		4,555 2.98 US$13,573
2024-08-21 2024-08-19 S Sale
1.7
SCIASCIA THOMAS

Chief Scientific Officer

Officer
16,496 -7.0%
2.96
US$48,883 		16,496 -7.0% 2.96 US$48,883
2024-08-16 2024-08-16 S Sale
1.7
SCIASCIA THOMAS

Chief Scientific Officer

Officer
18,660 -7.8%
2.76
US$51,440 		18,660 -7.8% 2.76 US$51,440
2024-08-16 2024-08-15 S Sale
1.7
SCIASCIA THOMAS

Chief Scientific Officer

Officer
12,745 -5.5%
2.79
US$35,513 		12,745 -5.5% 2.79 US$35,513
2024-08-15 2024-08-15 PrS Proposed sale
1.7
SCIASCIA THOMAS

Officer

Officer
48,001
2.61
US$125,282 		48,001 2.61 US$125,282
2024-08-15 2024-08-15 PrS Proposed sale
1.7
SCIASCIA THOMAS

Officer

Officer
48,001
2.61
US$125,282 		48,001 2.61 US$125,282
2024-08-16 2024-08-14 S Sale
1.7
SCIASCIA THOMAS

Chief Scientific Officer

Officer
100 -0.0%
2.75
US$275 		100 -0.0% 2.75 US$275
2024-05-31 2024-05-29 PlS Planned sale
1.7
SCIASCIA THOMAS

Chief Scientific Officer

Officer
53,368 -19.9%
2.55
US$136,110 		53,368 -19.9% 2.55 US$136,110
2024-05-29 2024-05-29 PrS Proposed sale
1.7
SCIASCIA THOMAS

Officer

Officer
53,368
2.56
US$136,622 		53,368 2.56 US$136,622
2024-05-24 2024-05-22 PlS Planned sale
Delfini Lisa

Chief Financial Officer

Officer
4,350 -7.5%
2.64
US$11,485 		4,350 -7.5% 2.64 US$11,485
2024-05-22 2024-05-20 S Sale
2.9
GOOD JENNIFER L

President & CEO

Executive Director
25,037 -10.5%
2.86
US$71,576 		25,037 -10.5% 2.86 US$71,576
2024-05-14 2024-05-10 PlS Planned sale
2.9
GOOD JENNIFER L

President & CEO

Executive Director
4,578 -2.1%
2.90
US$13,276 		4,578 -2.1% 2.90 US$13,276
2023-10-12 2023-10-11 PlS Planned sale
Delfini Lisa

Chief Financial Officer

Officer
785 -2.1%
2.02
US$1,586 		785 -2.1% 2.02 US$1,586
2023-09-13 2023-09-11 PlS Planned sale
Delfini Lisa

Chief Financial Officer

Officer
711 -2.0%
2.20
US$1,564 		711 -2.0% 2.20 US$1,564
2023-09-11 2023-09-11 PrS Proposed sale
Delfini Lisa

Officer

Officer
1,600
2.16
US$3,456 		1,600 2.16 US$3,456
2023-08-14 2023-08-11 PlS Planned sale
Delfini Lisa

Chief Financial Officer

Officer
682 -2.0%
2.36
US$1,610 		682 -2.0% 2.36 US$1,610
2023-07-12 2023-07-11 PlS Planned sale
Delfini Lisa

Chief Financial Officer

Officer
687 -2.2%
2.34
US$1,608 		687 -2.2% 2.34 US$1,608
2023-06-14 2023-06-12 PlS Planned sale
Delfini Lisa

Chief Financial Officer

Officer
610 -2.0%
2.64
US$1,610 		610 -2.0% 2.64 US$1,610
2023-06-12 2023-06-12 PrS Proposed sale
Delfini Lisa

Officer

Officer
1,615
2.57
US$4,150 		1,615 2.57 US$4,150
2023-05-15 2023-05-11 PlS Planned sale
Delfini Lisa

Chief Financial Officer

Officer
562 -2.0%
2.89
US$1,624 		562 -2.0% 2.89 US$1,624
2023-04-12 2023-04-11 PlS Planned sale
Delfini Lisa

Chief Financial Officer

Officer
840 -3.1%
1.84
US$1,545 		840 -3.1% 1.84 US$1,545
2023-04-11 2023-04-11 PrS Proposed sale
Delfini Lisa

Officer

Officer
1,900
1.84
US$3,496 		1,900 1.84 US$3,496
2023-03-15 2023-03-13 PlS Planned sale
Delfini Lisa

Chief Financial Officer

Officer
892 -3.5%
1.75
US$1,564 		892 -3.5% 1.75 US$1,564
2023-02-15 2023-02-13 PlS Planned sale
Delfini Lisa

Chief Financial Officer

Officer
8,474 -26.6%
2.45
US$20,761 		8,474 -26.6% 2.45 US$20,761
2022-07-06 2022-07-05 S Sale
3.0
TPG GP A, LLC
63,569 -1.6%
3.11
US$197,827 		63,569 -1.6% 3.11 US$197,827
2022-07-06 2022-07-01 S Sale
3.0
TPG GP A, LLC
436,431 -10.1%
2.86
US$1,246,185 		436,431 -10.1% 2.86 US$1,246,185
2022-07-01 2022-06-30 S Sale
3.0
TPG GP A, LLC
Large shareholder
429,838 -9.0%
2.77
US$1,191,898 		429,838 -9.0% 2.77 US$1,191,898
2022-07-01 2022-06-29 S Sale
3.0
TPG GP A, LLC
Large shareholder
46,128 -1.0%
2.74
US$126,303 		46,128 -1.0% 2.74 US$126,303
2022-05-04 2022-05-02 S Sale
3.0
TPG GP A, LLC
Large shareholder
600 -0.0%
2.70
US$1,620 		600 -0.0% 2.70 US$1,620
2022-05-02 2022-04-29 S Sale
3.0
TPG GP A, LLC
Large shareholder
16,163 -0.3%
2.75
US$44,385 		16,163 -0.3% 2.75 US$44,385
2022-05-02 2022-04-28 S Sale
3.0
TPG GP A, LLC
Large shareholder
7,271 -0.2%
2.77
US$20,140 		7,271 -0.2% 2.77 US$20,140
2022-04-13 2022-04-11 B Purchase
1.2
New Enterprise Associates 16, L.P.
Large shareholder
2,631,578 +33.8%
1.90
US$4,999,998 		2,631,578 +33.8% 1.90 US$4,999,998
2022-04-13 2022-04-11 B Purchase
2.5
BASKETT FOREST
Large shareholder
2,631,578 +33.8%
1.90
US$4,999,998 		2,631,578 +33.8% 1.90 US$4,999,998
2022-04-13 2022-04-11 B Purchase
3.9
Walker Paul Edward
Large shareholder
948,948 +inf%
1.90
US$1,803,001 		948,948 +inf% 1.90 US$1,803,001
2022-04-13 2022-04-11 B Purchase
3.9
Walker Paul Edward
Large shareholder
2,631,578 +33.8%
1.90
US$4,999,998 		2,631,578 +33.8% 1.90 US$4,999,998
2022-04-13 2022-04-11 B Purchase
2.8
Makhzoumi Mohamad
Large shareholder
948,948 +inf%
1.90
US$1,803,001 		948,948 +inf% 1.90 US$1,803,001
2022-04-13 2022-04-11 B Purchase
2.8
Makhzoumi Mohamad
Large shareholder
2,631,578 +33.8%
1.90
US$4,999,998 		2,631,578 +33.8% 1.90 US$4,999,998
2022-04-13 2022-04-11 B Purchase
1.5
Behbahani Ali
Large shareholder
948,948 +inf%
1.90
US$1,803,001 		948,948 +inf% 1.90 US$1,803,001
2022-04-13 2022-04-11 B Purchase
1.5
Behbahani Ali
Large shareholder
2,631,578 +33.8%
1.90
US$4,999,998 		2,631,578 +33.8% 1.90 US$4,999,998
2022-04-13 2022-04-11 B Purchase
2.4
SANDELL SCOTT D
Large shareholder
948,948 +inf%
1.90
US$1,803,001 		948,948 +inf% 1.90 US$1,803,001
2022-04-13 2022-04-11 B Purchase
2.4
SANDELL SCOTT D
Large shareholder
2,631,578 +33.8%
1.90
US$4,999,998 		2,631,578 +33.8% 1.90 US$4,999,998
2022-04-13 2022-04-11 B Purchase
3.6
Chang Carmen
Large shareholder
948,948 +inf%
1.90
US$1,803,001 		948,948 +inf% 1.90 US$1,803,001
2022-04-13 2022-04-11 B Purchase
3.6
Chang Carmen
Large shareholder
2,631,578 +33.8%
1.90
US$4,999,998 		2,631,578 +33.8% 1.90 US$4,999,998
2022-04-13 2022-04-11 B Purchase
2.1
Sonsini Peter W.
Large shareholder
948,948 +inf%
1.90
US$1,803,001 		948,948 +inf% 1.90 US$1,803,001
2022-04-13 2022-04-11 B Purchase
2.1
Sonsini Peter W.
Large shareholder
2,631,578 +33.8%
1.90
US$4,999,998 		2,631,578 +33.8% 1.90 US$4,999,998
2022-04-13 2022-04-11 B Purchase
2.7
Florence Anthony A. Jr.
Large shareholder
948,948 +inf%
1.90
US$1,803,001 		948,948 +inf% 1.90 US$1,803,001
2022-04-13 2022-04-11 B Purchase
2.7
Florence Anthony A. Jr.
Large shareholder
2,631,578 +33.8%
1.90
US$4,999,998 		2,631,578 +33.8% 1.90 US$4,999,998
2021-10-19 2021-10-18 B Purchase
1.2
New Enterprise Associates 16, L.P.
Large shareholder
1,851,852
0.00
US$0 		1,851,852 0.00 US$0
2021-10-19 2021-10-18 B Purchase
1.5
Behbahani Ali
Large shareholder
1,851,852
0.00
US$0 		1,851,852 0.00 US$0
2021-10-19 2021-10-18 B Purchase
3.6
Chang Carmen
Large shareholder
1,851,852
0.00
US$0 		1,851,852 0.00 US$0
2021-10-19 2021-10-18 B Purchase
2.5
BASKETT FOREST
Large shareholder
1,851,852
0.00
US$0 		1,851,852 0.00 US$0
2021-10-19 2021-10-18 B Purchase
2.7
Florence Anthony A. Jr.
Large shareholder
1,851,852
0.00
US$0 		1,851,852 0.00 US$0
2021-10-19 2021-10-18 B Purchase
2.8
Makhzoumi Mohamad
Large shareholder
1,851,852
0.00
US$0 		1,851,852 0.00 US$0
2021-10-19 2021-10-18 B Purchase
2.4
SANDELL SCOTT D
Large shareholder
1,851,852
0.00
US$0 		1,851,852 0.00 US$0
Explore more

More insider trading research around Trevi Therapeutics, Inc.

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America